Total Payments
$5,612
2024 Payments
$448.65
Companies
36
Transactions
323
Medicare Patients
5,291
Medicare Billing
$448,912
Payment Breakdown by Category
Food & Beverage$5,546 (98.8%)
Education$65.88 (1.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,546 | 321 | 98.8% |
| Education | $65.88 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,765 | 93 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $758.63 | 35 | $0 (2024) |
| Lilly USA, LLC | $489.39 | 34 | $0 (2024) |
| ABBVIE INC. | $389.08 | 37 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $329.58 | 15 | $0 (2022) |
| Amgen Inc. | $310.62 | 15 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $302.52 | 16 | $0 (2024) |
| PFIZER INC. | $234.65 | 15 | $0 (2024) |
| Abbott Laboratories | $216.71 | 12 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $110.47 | 9 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $448.65 | 27 | Novo Nordisk Inc ($174.96) |
| 2023 | $798.49 | 45 | Novo Nordisk Inc ($312.68) |
| 2022 | $928.48 | 66 | Novo Nordisk Inc ($257.99) |
| 2021 | $1,213 | 78 | Novo Nordisk Inc ($328.46) |
| 2020 | $588.10 | 34 | Novo Nordisk Inc ($183.49) |
| 2019 | $868.50 | 45 | Novo Nordisk Inc ($321.37) |
| 2018 | $766.61 | 28 | AstraZeneca Pharmaceuticals LP ($335.86) |
All Payment Transactions
323 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.64 | General |
| Category: Gastroenterology | ||||||
| 11/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.76 | General |
| Category: Diabetes | ||||||
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Obesity | ||||||
| 09/17/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: PAIN | ||||||
| 08/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.85 | General |
| 08/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.94 | General |
| Category: VACCINES | ||||||
| 08/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.43 | General |
| Category: Obesity | ||||||
| 08/05/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Diabetes Care | ||||||
| 06/26/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.88 | General |
| Category: Diabetes | ||||||
| 06/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.44 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: Endocrinology | ||||||
| 04/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: Diabetes | ||||||
| 04/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: PAIN | ||||||
| 03/21/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Diabetes | ||||||
| 03/13/2024 | Lilly USA, LLC | JARDIANCE (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.87 | General |
| Category: Diabetes | ||||||
| 03/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/22/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Diabetes | ||||||
| 02/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.47 | General |
| Category: VACCINES | ||||||
| 02/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $17.26 | General |
| 01/31/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Inflammation | ||||||
| 01/30/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.90 | General |
| Category: Respiratory | ||||||
| 01/25/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.22 | General |
| Category: Diabetes | ||||||
| 01/19/2024 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $14.73 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 1,639 | 3,151 | $295,884 | $146,582 |
| 2022 | 22 | 1,223 | 2,203 | $227,148 | $81,751 |
| 2021 | 25 | 1,272 | 2,124 | $239,862 | $123,758 |
| 2020 | 20 | 1,157 | 2,188 | $225,599 | $96,821 |
Total Patients
5,291
Total Services
9,666
Medicare Billing
$448,912
Procedure Codes
91
All Medicare Procedures & Services
91 procedure records from CMS Medicare Utilization — Page 3 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87428 | Sarscov & inf vir a&b ag ia | Office | 2021 | 53 | 59 | $10,325 | $4,262 | 41.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 34 | 69 | $6,762 | $3,397 | 50.2% |
| 99309 | Subsequent nursing facility visit, typically 25 minutes per day | Office | 2021 | 26 | 47 | $6,110 | $3,349 | 54.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 45 | 45 | $4,500 | $2,871 | 63.8% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 43 | 43 | $4,300 | $2,856 | 66.4% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 13 | 13 | $4,290 | $2,788 | 65.0% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Office | 2021 | 30 | 31 | $5,610 | $2,688 | 47.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 22 | 22 | $5,126 | $2,640 | 51.5% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 83 | 211 | $9,284 | $2,049 | 22.1% |
| 87426 | Elisa detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | Office | 2021 | 41 | 44 | $3,300 | $1,945 | 58.9% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2021 | 25 | 69 | $4,416 | $1,748 | 39.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 91 | 93 | $2,325 | $1,447 | 62.2% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 17 | 17 | $2,584 | $1,170 | 45.3% |
| 0013A | Fee covid-19 vac 2 booster | Office | 2021 | 16 | 16 | $720.00 | $591.04 | 82.1% |
| 87804 | Detection test by immunoassay for influenza virus | Office | 2021 | 14 | 30 | $1,500 | $496.50 | 33.1% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 33 | 46 | $2,070 | $403.56 | 19.5% |
| 81002 | Urinalysis, manual test | Office | 2021 | 44 | 64 | $1,024 | $222.72 | 21.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 14 | 14 | $350.00 | $204.54 | 58.4% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2021 | 18 | 26 | $520.00 | $178.92 | 34.4% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2021 | 20 | 20 | $960.00 | $124.60 | 13.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2021 | 16 | 97 | $242.50 | $9.94 | 4.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 311 | 819 | $135,135 | $55,474 | 41.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 164 | 185 | $20,905 | $9,095 | 43.5% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Office | 2020 | 52 | 212 | $13,568 | $6,571 | 48.4% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 84 | 88 | $8,800 | $5,324 | 60.5% |
About Dr. Daniel Holdman, MD
Dr. Daniel Holdman, MD is a Family Medicine healthcare provider based in Bartlesville, Oklahoma. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/18/2008. The National Provider Identifier (NPI) number assigned to this provider is 1972768919.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Holdman, MD has received a total of $5,612 in payments from pharmaceutical and medical device companies, with $448.65 received in 2024. These payments were reported across 323 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($5,546).
As a Medicare-enrolled provider, Holdman has provided services to 5,291 Medicare beneficiaries, totaling 9,666 services with total Medicare billing of $448,912. Data is available for 4 years (2020–2023), covering 91 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Bartlesville, OK
- Active Since 07/18/2008
- Last Updated 10/19/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1972768919
Products in Payments
- Ozempic (Drug) $940.10
- FARXIGA (Drug) $541.46
- XARELTO (Drug) $329.58
- JARDIANCE (Drug) $319.27
- Rybelsus (Drug) $275.00
- TRULICITY (Drug) $190.39
- RYBELSUS (Drug) $180.05
- QULIPTA (Drug) $176.60
- UBRELVY (Drug) $158.78
- Wegovy (Drug) $139.39
- SYMBICORT (Drug) $127.51
- Otezla (Drug) $123.31
- MOUNJARO (Drug) $112.16
- VRAYLAR (Drug) $106.95
- Repatha (Biological) $105.25
- NURTEC ODT (Drug) $98.42
- FREESTYLE LIBRE 3 (Device) $91.14
- FREESTYLE LIBRE 2 (Device) $87.83
- EMGALITY (Drug) $76.36
- Saxenda (Drug) $67.47
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bartlesville
Mark Erhardt, D.o, D.O
Family Medicine — Payments: $7,806
Family Medicine $7,806
Elizabeth Sherrock, M.d, M.D
Family Medicine — Payments: $6,925
Family Medicine $6,925
William Davito, D.o, D.O
Family Medicine — Payments: $4,991
Family Medicine $4,991
Michael Vaclaw, M.d, M.D
Family Medicine — Payments: $4,027
Family Medicine $4,027
Ashley Estep, Do, DO
Family Medicine — Payments: $3,276
Family Medicine $3,276
Gerald Pribil, Md, MD
Family Medicine — Payments: $2,266
Family Medicine $2,266